Analyze Diet
Journal of immunology (Baltimore, Md. : 1950)2007; 179(6); 4161-4169; doi: 10.4049/jimmunol.179.6.4161

Herpesvirus chemokine-binding glycoprotein G (gG) efficiently inhibits neutrophil chemotaxis in vitro and in vivo.

Abstract: Glycoprotein G (gG) of alphaherpesviruses has been described to function as a viral chemokine-binding protein (vCKBP). More recently, mutant viruses devoid of gG have been shown to result in increased virulence, but it remained unclear whether the potential of gG to serve as a vCKBP is responsible for this observation. In this study, we used equine herpesvirus type 1 (EHV-1) as a model to study the pathophysiological importance of vCKBP activity. First, in vitro chemotaxis assays studying migration of immune cells, an important function of chemokines, were established. In such assays, supernatants of EHV-1-infected cells significantly inhibited IL-8-induced chemotaxis of equine neutrophils. Identification of gG as the responsible vCKBP was achieved by repeating similar experiments with supernatants from cells infected with a gG-negative mutant, which were unable to alter IL-8-induced equine neutrophil migration. Furthermore, rEHV-1 gG was able to significantly reduce neutrophil migration, establishing gG as a bona fide vCKBP. Second, and importantly, in vivo analyses in a murine model of EHV-1 infection showed that neutrophil migration in the target organ lung was significantly reduced in the presence of gG. In summary, we demonstrate for the first time that EHV-1 gG not only binds to chemokines but is also capable of inhibiting their chemotactic function both in vitro and in vivo, thereby contributing to viral pathogenesis and virulence.
Publication Date: 2007-09-06 PubMed ID: 17785855DOI: 10.4049/jimmunol.179.6.4161Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research paper investigates how the glycoprotein G (gG) of alphaherpesviruses inhibits the movement of immune cells, contributing to increased virulence of infections. The study uses the equine herpesvirus type 1 (EHV-1) as a model and demonstrates that its gG successfully interferes with both in vitro and in vivo activities of immune cells in response to viral infections.

Objective and Methodology

  • The main objective of this study was to determine the role of viral chemokine-binding protein (vCKBP) gG, found in alphaherpesviruses, in inhibiting the chemotactic function of immune cells.
  • This was accomplished by studying the activities of the equine herpesvirus type 1 (EHV-1) using both in vitro and in vivo models.
  • The researchers performed chemotaxis assays, which measure the migration of cells in response to certain stimuli, in this case caused by infection with EHV-1.

In Vitro Findings

  • In the in vitro tests, the researchers found that supernatants from EHV-1-infected cells considerably hindered the IL-8-induced chemotaxis of equine neutrophils, an important immune response to infection.
  • This inhibitory effect was linked to gG, since when similar experiments were conducted with supernatants from cells infected with a gG-deficient mutant, they failed to alter the IL-8-induced movement of neutrophils.
  • The researchers also discovered that recombinant EHV-1 gG could effectively limit neutrophil migration, confirming gG’s function as an integral vCKBP.

In Vivo Findings

  • In vivo analysis in a mouse model of EHV-1 infection revealed that gG presence significantly reduced the migration of neutrophils in the target organ lung, confirming the in vitro findings.
  • This significant reduction in neutrophil movement would limit the immune response to the viral infection, thus increasing the virulence of the disease.

Conclusion

  • The study concludes that EHV-1 gG not only binds to chemokines but also hampers their chemotactic function both in vitro and in vivo, contributing to increased severity of viral infections.
  • This study highlights the importance of studying the role of proteins like gG in virus pathogenesis, which can lead to better understanding and treatment of viral infections.

Cite This Article

APA
Van de Walle GR, May ML, Sukhumavasi W, von Einem J, Osterrieder N. (2007). Herpesvirus chemokine-binding glycoprotein G (gG) efficiently inhibits neutrophil chemotaxis in vitro and in vivo. J Immunol, 179(6), 4161-4169. https://doi.org/10.4049/jimmunol.179.6.4161

Publication

ISSN: 0022-1767
NlmUniqueID: 2985117R
Country: United States
Language: English
Volume: 179
Issue: 6
Pages: 4161-4169

Researcher Affiliations

Van de Walle, Gerlinde R
  • Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.
May, Maeva L
    Sukhumavasi, Woraporn
      von Einem, Jens
        Osterrieder, Nikolaus

          MeSH Terms

          • Animals
          • Binding, Competitive / immunology
          • Cell Line
          • Cell Migration Inhibition
          • Cell-Free System / immunology
          • Chemokine CCL2 / metabolism
          • Chemokine CCL2 / physiology
          • Chemokines / metabolism
          • Chemotaxis, Leukocyte / immunology
          • Female
          • Herpesviridae Infections / immunology
          • Herpesviridae Infections / metabolism
          • Herpesviridae Infections / pathology
          • Herpesvirus 1, Equid / immunology
          • Herpesvirus 1, Equid / pathogenicity
          • Horses
          • Interleukin-8 / antagonists & inhibitors
          • Interleukin-8 / physiology
          • Mice
          • Neutrophils / cytology
          • Neutrophils / immunology
          • Neutrophils / virology
          • Pneumonia, Viral / immunology
          • Pneumonia, Viral / metabolism
          • Pneumonia, Viral / pathology
          • Protein Binding / immunology
          • Rabbits
          • Viral Envelope Proteins / deficiency
          • Viral Envelope Proteins / genetics
          • Viral Envelope Proteins / metabolism
          • Viral Envelope Proteins / physiology
          • Virulence

          Citations

          This article has been cited 21 times.
          1. Zarski LM, Vaala WE, Barnett DC, Bain FT, Soboll Hussey G. A Live-Attenuated Equine Influenza Vaccine Stimulates Innate Immunity in Equine Respiratory Epithelial Cell Cultures That Could Provide Protection From Equine Herpesvirus 1.. Front Vet Sci 2021;8:674850.
            doi: 10.3389/fvets.2021.674850pubmed: 34179166google scholar: lookup
          2. Laval K, Poelaert KCK, Van Cleemput J, Zhao J, Vandekerckhove AP, Gryspeerdt AC, Garré B, van der Meulen K, Baghi HB, Dubale HN, Zarak I, Van Crombrugge E, Nauwynck HJ. The Pathogenesis and Immune Evasive Mechanisms of Equine Herpesvirus Type 1.. Front Microbiol 2021;12:662686.
            doi: 10.3389/fmicb.2021.662686pubmed: 33746936google scholar: lookup
          3. Harman RM, Patel RS, Fan JC, Park JE, Rosenberg BR, Van de Walle GR. Single-cell RNA sequencing of equine mesenchymal stromal cells from primary donor-matched tissue sources reveals functional heterogeneity in immune modulation and cell motility.. Stem Cell Res Ther 2020 Dec 4;11(1):524.
            doi: 10.1186/s13287-020-02043-5pubmed: 33276815google scholar: lookup
          4. Mehta AY, Heimburg-Molinaro J, Cummings RD, Goth CK. Emerging patterns of tyrosine sulfation and O-glycosylation cross-talk and co-localization.. Curr Opin Struct Biol 2020 Jun;62:102-111.
            doi: 10.1016/j.sbi.2019.12.002pubmed: 31927217google scholar: lookup
          5. Coppo MJC, Devlin JM, Legione AR, Vaz PK, Lee SW, Quinteros JA, Gilkerson JR, Ficorilli N, Reading PC, Noormohammadi AH, Hartley CA. Infectious Laryngotracheitis Virus Viral Chemokine-Binding Protein Glycoprotein G Alters Transcription of Key Inflammatory Mediators In Vitro and In Vivo.. J Virol 2018 Jan 1;92(1).
            doi: 10.1128/JVI.01534-17pubmed: 29070686google scholar: lookup
          6. Pontejo SM, Murphy PM. Chemokines encoded by herpesviruses.. J Leukoc Biol 2017 Nov;102(5):1199-1217.
            doi: 10.1189/jlb.4RU0417-145RRpubmed: 28848041google scholar: lookup
          7. González-Motos V, Jürgens C, Ritter B, Kropp KA, Durán V, Larsen O, Binz A, Ouwendijk WJD, Lenac Rovis T, Jonjic S, Verjans GMGM, Sodeik B, Krey T, Bauerfeind R, Schulz TF, Kaufer BB, Kalinke U, Proudfoot AEI, Rosenkilde MM, Viejo-Borbolla A. Varicella zoster virus glycoprotein C increases chemokine-mediated leukocyte migration.. PLoS Pathog 2017 May;13(5):e1006346.
            doi: 10.1371/journal.ppat.1006346pubmed: 28542541google scholar: lookup
          8. Zhao J, Poelaert KCK, Van Cleemput J, Nauwynck HJ. CCL2 and CCL5 driven attraction of CD172a(+) monocytic cells during an equine herpesvirus type 1 (EHV-1) infection in equine nasal mucosa and the impact of two migration inhibitors, rosiglitazone (RSG) and quinacrine (QC).. Vet Res 2017 Feb 27;48(1):14.
            doi: 10.1186/s13567-017-0419-4pubmed: 28241864google scholar: lookup
          9. Baker L, Chitas AM, Hartley CA, Coppo MJ, Vaz PK, Stent A, Gilkerson JR, Devlin JM, Every AL. Recombinant herpesvirus glycoprotein G improves the protective immune response to Helicobacter pylori vaccination in a mouse model of disease.. PLoS One 2014;9(5):e96563.
            doi: 10.1371/journal.pone.0096563pubmed: 24794215google scholar: lookup
          10. Maes R. Felid herpesvirus type 1 infection in cats: a natural host model for alphaherpesvirus pathogenesis.. ISRN Vet Sci 2012;2012:495830.
            doi: 10.5402/2012/495830pubmed: 23762586google scholar: lookup
          11. Engel AT, Selvaraj RK, Kamil JP, Osterrieder N, Kaufer BB. Marek's disease viral interleukin-8 promotes lymphoma formation through targeted recruitment of B cells and CD4+ CD25+ T cells.. J Virol 2012 Aug;86(16):8536-45.
            doi: 10.1128/JVI.00556-12pubmed: 22647701google scholar: lookup
          12. Viejo-Borbolla A, Martinez-Martín N, Nel HJ, Rueda P, Martín R, Blanco S, Arenzana-Seisdedos F, Thelen M, Fallon PG, Alcamí A. Enhancement of chemokine function as an immunomodulatory strategy employed by human herpesviruses.. PLoS Pathog 2012 Feb;8(2):e1002497.
            doi: 10.1371/journal.ppat.1002497pubmed: 22319442google scholar: lookup
          13. Azab W, El-Sheikh A, Abdel-Gawad A. In vitro characterization of EHV-4 gG-deleted mutant.. Virus Genes 2012 Feb;44(1):109-11.
            doi: 10.1007/s11262-011-0677-6pubmed: 21960433google scholar: lookup
          14. Li X, Liang D, Lin X, Robertson ES, Lan K. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen reduces interleukin-8 expression in endothelial cells and impairs neutrophil chemotaxis by degrading nuclear p65.. J Virol 2011 Sep;85(17):8606-15.
            doi: 10.1128/JVI.00733-11pubmed: 21697472google scholar: lookup
          15. Soboll Hussey G, Hussey SB, Wagner B, Horohov DW, Van de Walle GR, Osterrieder N, Goehring LS, Rao S, Lunn DP. Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant.. Vet Res 2011 Feb 7;42(1):23.
            doi: 10.1186/1297-9716-42-23pubmed: 21314906google scholar: lookup
          16. Alcami A, Lira SA. Modulation of chemokine activity by viruses.. Curr Opin Immunol 2010 Aug;22(4):482-7.
            doi: 10.1016/j.coi.2010.06.004pubmed: 20598516google scholar: lookup
          17. Fulton A, Peters ST, Perkins GA, Jarosinski KW, Damiani A, Brosnahan M, Buckles EL, Osterrieder N, Van de Walle GR. Effective treatment of respiratory alphaherpesvirus infection using RNA interference.. PLoS One 2009;4(1):e4118.
            doi: 10.1371/journal.pone.0004118pubmed: 19122813google scholar: lookup
          18. Van de Walle GR, Peters ST, VanderVen BC, O'Callaghan DJ, Osterrieder N. Equine herpesvirus 1 entry via endocytosis is facilitated by alphaV integrins and an RSD motif in glycoprotein D.. J Virol 2008 Dec;82(23):11859-68.
            doi: 10.1128/JVI.00868-08pubmed: 18815313google scholar: lookup
          19. Wuest TR, Carr DJ. The role of chemokines during herpes simplex virus-1 infection.. Front Biosci 2008 May 1;13:4862-72.
            doi: 10.2741/3045pubmed: 18508551google scholar: lookup
          20. Van de Walle GR, Jarosinski KW, Osterrieder N. Alphaherpesviruses and chemokines: pas de deux not yet brought to perfection.. J Virol 2008 Jul;82(13):6090-7.
            doi: 10.1128/JVI.00098-08pubmed: 18385255google scholar: lookup
          21. Van de Walle GR, Sakamoto K, Osterrieder N. CCL3 and viral chemokine-binding protein gg modulate pulmonary inflammation and virus replication during equine herpesvirus 1 infection.. J Virol 2008 Feb;82(4):1714-22.
            doi: 10.1128/JVI.02137-07pubmed: 18077722google scholar: lookup